How Much Does GLP-1 Cost Without Insurance in 2027?

What does GLP-1 medication cost without insurance heading into 2027?

Across the 18 programs in this comparison, a standard month-to-month compounded injectable plan starts at $149 a month for semaglutide (Idgie Health) and $199 a month for tirzepatide (Renlo Health). Those are the cheapest figures the site has verified for each molecule, not typical ones — the recorded spread is $1,349 between the cheapest and dearest semaglutide plan, and $1,629 between the tirzepatide extremes. What a buyer actually pays depends on three things a headline price rarely shows.

• The billing interval. A figure quoted every four weeks is not a calendar month: on a 28-day cycle a year holds thirteen charges, not twelve.
• The membership structure. 0 of these programs bill a membership beside the medication, so the medication figure is not the bill; 16 charge no separate fee or fold it into the one charge.
• The dose policy. A plan that prices by dose can start low and climb. A published “from” figure is a floor, not the amount that will be charged at a higher dose.

So the practical answer is a range, not a slogan: a cash-pay GLP-1 plan is roughly a low three-figure sum each month, and the difference between two plans on the same molecule can be larger than the difference between the two molecules. The sections below use the recorded figures rather than an average, because an average would describe no program anyone can actually buy.

This page is about total cash-pay program expense and choosing a payment arrangement. The molecule-level arithmetic — which charge belongs to which billing cycle, and what a branded plan costs beside a compounded one — is worked through in the semaglutide cost guide and the tirzepatide cost guide.

Semaglutide versus tirzepatide monthly costs

Two molecules, two price patterns. The records carry a standalone monthly figure for 18 ranked programs on semaglutide and 16 on tirzepatide, and the two lists are not the same shape. Semaglutide records the lower entry price of the two, by $50 a month. The cheaper entry point does not settle the rest of the list: the recorded spread is $1,349 across semaglutide plans and $1,629 across tirzepatide plans, so a program that leads on one molecule can sit well down the list on the other.

Two cautions about reading those two numbers together. First, a program that leads on one molecule can sit well down the list on the other, so the cheapest semaglutide plan is not automatically the cheapest tirzepatide plan — the table below prints both columns per row for exactly that reason. Second, a molecule is not a choice a buyer makes at checkout: it is a prescription decision, so the useful question is which plans price the molecule you are actually prescribed competitively.

Real provider price comparison

Every row below is a researched price record with a check date behind it, read from the same offer data the comparison ledger and the buyer guide use. The order is the cheapest verified monthly figure each program records, not the publisher’s editorial ranking, because the question here is what a month costs rather than which program is judged best overall. The program’s rank travels with the row so both orders stay visible.

One figure deliberately does not appear in that table: the advertiser-supplied placement carried by the ranked index. Its amounts were supplied by the advertiser rather than researched, so it is excluded here rather than mixed into a price sort, and it is labeled as sponsored wherever it does appear. A program that publishes only a “from” starting point is excluded from the sort for the same reason — 3 ranked program does exactly that, and its floor is printed on its own profile instead of being presented as a monthly price.

The full ledger adds the fields a table cannot hold comfortably: the required one-time charges, the cancellation terms and the exact wording each provider uses. Read every recorded plan or start with the ranked buyer guide.

Which providers charge a separate membership fee?

A membership fee is one of the most common reasons a quoted medication price does not match the amount taken from an account. It is also the easiest thing to check, because it is a separate line rather than a different interpretation of the same number. In this set, 0 programs bill one, 16 either state $0 or include it inside the recorded charge, and 2 leave the amount unrecorded.

The distinction that matters for budgeting: a bundled price is not automatically cheaper. A program can carry the same overhead inside a higher medication figure, which is why the membership column and the price column have to be read together rather than one after the other. What bundling buys is predictability — one charge, one date, no second line to reconcile. The membership fee ledger prints the amount and the billing structure program by program.

How no-membership programs compare

16 programs in this set record either a stated $0 membership or a membership already inside the charge, so their printed monthly figure is the amount billed. Sorted by that figure, the leading entries are not all the same program:

• Idgie Health$149 semaglutide · $229 tirzepatide · $0 membership
• OrderlyMeds$149 semaglutide · $299 tirzepatide · $0 membership
• Surfbound Health$169 semaglutide · $219 tirzepatide · $0 membership
• Cora Health$175 semaglutide · $225 tirzepatide · $0 membership
• Ozari Health$175 semaglutide · $235 tirzepatide · $0 membership
• Rx.com$175 semaglutide · $285 tirzepatide · $0 membership

The comparison to make inside this group is not the membership line, which is settled, but the two prices. Idgie Health records the lowest figure of the group at $149 a month, and no other member records a lower figure on either molecule. A program with no separate fee still has to be checked for a one-time charge, a shipping condition and a dose policy — none of which is a membership, and all of which change the total.

Why a starting price sometimes differs from a continuing price

A first-month figure and an ongoing figure are two different facts, and programs are not obliged to present them in the same place. Four patterns account for almost every mismatch on a cash-pay page.

• A dose ladder. GLP-1 treatment is titrated upward. A program that prices per dose advertises the entry dose and charges more at the next step, so the advertised number is true for one stage of treatment rather than for the plan.
• A published floor. The word “from” is doing real work. 3 ranked program publishes a floor rather than a figure, and this comparison excludes those cells from the price sort instead of treating them as a monthly charge.
• A first-month or promotional rate. A discounted first charge reverts to the standard rate on the next billing period. If the renewal amount is not published, month two is unknown rather than equal to month one.
• A prepaid package. Paying for several months up front at a lower rate produces a low average and a large first transaction. The average is a description of money already paid, not a recurring charge.

The check that resolves all four is the same question asked in the same order: what is charged at the next billing period, at the dose I will be on, with every mandatory fee included? A program that can answer that in one sentence is comparable. One that answers with a first-month figure has told you something, just not that. Reading a first charge goes through the field-by-field version.

What shipping, clinical reviews and other fees add

Cash-pay GLP-1 programs are usually described as all-inclusive, and most of them are. The exceptions are worth knowing because none of them appears in the headline number.

• Provider review. Where review is inside the charge, the monthly figure covers the consultation and the prescription decision. Where it is billed separately, it behaves like a membership and should be added to the monthly comparison. The membership column above captures the separate cases the records establish.
• Shipping. Where a record states that standard delivery is inside the charge, it is already in the figure. Where a program bills delivery, or charges more for expedited shipping, that is a per-shipment cost a monthly figure cannot represent — worth confirming before treating a quoted amount as the whole bill.
• One-time charges. An initial consultation, a lab requirement or a one-time onboarding fee is charged once and is not a monthly cost — which is exactly why it is easy to overlook when comparing monthly figures. These are recorded as their own line in the ledger, never summed into a monthly number.
• Taxes and card fees. Where a program collects sales tax on a medication, the amount taken will exceed the published figure. No figure on this page is tax-inclusive.

The practical consequence is small and compounding: two plans that differ by one hidden $10 line differ by $120 over a year, which is more than the gap between several of the recorded plans in the table. The cost calculator takes medication price, membership, shipping and a one-time fee and shows the total across three, six and twelve months.

How to budget for several months of treatment

A single month is the wrong unit for a treatment that runs for several. The arithmetic is simple, but it has to be done on the right number: the amount actually charged each period, not a promotional first charge and not a package average. The table below multiplies recorded monthly charges so the shape of a longer commitment is visible before anything is purchased.

Two structural points sit behind those totals and neither is arithmetic. First, a total across twelve periods assumes the price does not change; a program that raises its charge at a higher dose breaks that assumption, so the flat-price question matters more the longer the plan runs. Second, the billing cadence is not a calendar month. On Surfbound's recorded monthly figure, twelve charges come to $2,028 while a 28-day cadence would produce thirteen charges and $2,197 — one extra charge, $169, for the same calendar year. That difference is why this page keeps every charge on its own recorded interval instead of normalising them into a single monthly figure.

The other budgeting decision is the commitment. A prepaid package can cost less per period than paying month to month, and it is a long commitment by construction: it buys a lower rate with less room to stop. A month-to-month plan costs more per period and buys the ability to leave. Neither is the wrong answer, but they answer different questions. The month-to-month comparison and the cancellation ledger separate the term, the notice requirement and any cancellation charge.

What makes a low advertised price misleading?

Not every low price is misleading. Some programs are genuinely cheaper than others, and the cheapest row in the table above is a real record with a date on it. A figure becomes misleading when it describes something other than the recurring charge for a plan a reader can actually buy — usually in one of these ways.

1. It is an entry-dose price presented as a plan price. The number is real, but it holds for one stage of titration.
2. It excludes a mandatory membership. The medication is that price; the bill is that price plus a second line.
3. It is a package divided by its term. A lower average produced by paying more up front is not a lower monthly charge.
4. It expires without saying what replaces it. A first-month promotion with an unpublished renewal leaves the actual cost of the plan unknown.
5. It is supplied by the advertiser rather than researched. A paid placement can carry any figure the advertiser provides. It is labeled on this site for exactly that reason, and excluded from every price sort.

The test is not whether the number is low but whether it survives the second month at the prescribed dose. That standard is applied to every row in the table: a cell carries a figure only where a standard monthly charge was verified, and prints the reason when it was not.

Best value options from the researched provider set

Value here means one thing: the lowest verified ongoing monthly charge for the molecule, with no separate membership to add beside it. That is a narrower question than which program is best, and the two answers are allowed to differ.

The wider picture — every ranked program with its score, its recorded prices and the one limitation each one carries — is in Best online GLP-1 providers for 2027. This page deliberately does not repeat that ranking, because a price list and an editorial ranking answer different questions and should be allowed to disagree.

Questions buyers ask about cash-pay GLP-1 costs

How much is GLP-1 per month without insurance?

On the records checked for this guide, a standard month-to-month compounded injectable plan runs from $149 a month for semaglutide and $199 a month for tirzepatide at the cheapest verified programs. Most plans sit above those figures, and a separate membership fee or a dose-based increase can move the bill above the advertised medication price.

Is the cheapest advertised price the cheapest plan?

Often not. A first-month promotion, an entry-dose price or a package average can all produce a lower headline than the recurring charge. The reliable comparison is the amount billed at the next period, at the prescribed dose, with every mandatory fee included — which is the figure this page sorts on.

Do I have to pay a membership fee on top of the medication?

It depends on the program. 0 of the programs compared here bill a membership beside the medication, 16 charge none or include it, and 2 leave the amount unrecorded. An unrecorded amount is not a zero, so it should be confirmed before it is budgeted as free.

Does a 28-day price equal a monthly price?

No. A 28-day cycle produces thirteen charges in a calendar year, so a plan billed every four weeks costs one extra charge a year compared with an identical figure billed monthly. This page keeps each program’s own interval beside its price rather than converting it.

Are these 2027 prices?

No. They are 2026 records, checked between October 15–30, 2026, and they are the most recent verified figures available before 2027 begins. Nothing here forecasts a future increase or a future discount; when a provider changes a price, the record changes and this page follows it.

What should I check before entering payment details?

Four things: the amount charged at the second billing period, whether a membership or consultation is billed separately, whether the charge rises at a higher dose, and what cancellation requires. Each has a recorded answer on most provider profiles, and where it does not, the profile says so rather than filling the gap.

Evidence sources and dates checked

Every figure on this page is either read from a dated provider page or is arithmetic on figures that are. Nothing is estimated, converted from a package price or carried over from a previous year.

• Provider price records — 18 rows across 22 ranked programs of 81 documented profiles, each with the source page and check date on the program profile and in the ledger. Check dates fall between October 15–30, 2026.
• Surfbound Health published pricing (opens in a new tab) — source of the two published monthly figures and of the no-membership, flat-dose and included-review terms. Checked within the same window as the rest of the records.
• Method — what counts as a price, what a blank means and how a conflicting provider page is recorded rather than smoothed, on how we compare.
• Scope — oral plans, prepaid packages, microdose-only offers and promotional amounts are excluded from this comparison by the site’s standing rules, not by a rule invented for this page. The exclusion counts are published with the open dataset.

Compounded injectable products are not FDA-approved finished drug products and are not generic versions of a brand-name medication. Branded products, where a plan sells one, are recorded separately and are never pooled into a compounded price.